// App-Quantinova.ai

150 : Decreased Cancer Susceptibility in Tolerant Liver Transplant Recipients: Another Benefit of Tolerance?

Researchers

Presenter

  • M. P. Bhat

Principal Investigators

  • E. Pasini

  • C. Baciu

  • S. M. Kurian

  • J. Levitsky

Medical Centers

  • Multi-Organ Transplant, UHN, Toronto, ON, Canada

  • Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA

  • Divison of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • N/A

Drug/Treatment

  • Tacrolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved